1-20 of 204
Andrew M. Evens
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Molecular Subtyping of DLBCL Patients from the Oncology Research Information Exchange Network

Harsh R. Shah, Arjun Gramopadhye, Sierra Sky Nishizaki, Aarav Kukreja, Muhammad Khalid, Suresh Venkateswaran, Robert Rounbehler, Rich Johnston, Melissa Kives, Craig A. Portell, Emily Ayers, Javier Pinilla-Ibarz, Joanna M. Rhodes, Andrew M Evens, Yazeed Sawalha, David A. Bond, Kami J. Maddocks, Brian K. Link, Jonathon B. Cohen, Michelle Churchman
Journal: Blood
Blood (2024) 144 (Supplement 1): 6199.
https://doi.org/10.1182/blood-2024-204481
Published: 2024
Journal Articles

A Phase I/II Study of Tazemetostat Combined with Abbreviated Rituximab/Bendamustine Therapy for High Tumor Burden Follicular Lymphoma in Frontline Treatment: A Big Ten Cancer Research Consortium Study

Vaishalee P Kenkre, Yong Lin, Narendranath Epperla, Saurabh A Rajguru, Julie E Chang, Priyanka A. Pophali, Elyse I Harris, Christopher D Fletcher, Matthew Matasar, Hussam Eltoukhy, David A. Bond, Yazeed Sawalha, Beth Christian, Timothy Voorhees, Mariah Endres, Mitch Howard, Damayanti Bhavsar, Misty Fleming, Jordan S. Carter, Andrew M Evens
Journal: Blood
Blood (2024) 144 (Supplement 1): 4415.
https://doi.org/10.1182/blood-2024-202639
Published: 2024
Journal Articles

Outcomes of Autologous Stem Cell Transplant in Older Adults with Relapsed/Refractory Classic Hodgkin Lymphoma

Sanjal H. Desai, Michael A Spinner, Alice Sykorova, Veronika Bachanova, Andrew M Evens, Gaurav Goyal, Brad S. Kahl, Kathleen Dorritie, Jacques Azzi, Vaishalee P Kenkre, Cheryl Chang, Jozef Michalka, Stephen M. Ansell, Brendon Fusco, Nuttavut Sumransub, Haris Hatic, Raya Saba, Uroosa Ibrahim, Elyse I Harris, Harsh R. Shah, Nina Wagner-Johnston, Sally Arai, Grzegorz S. Nowakowski, Heidi Mocikova, Deepa Jagadeesh, Kristie A. Blum, Catherine S. Diefenbach, Siddharth Iyengar, K. C. Rappazzo, Firas Baidoun, Yun Choi, Vit Prochazka, Ranjana H. Advani, Ivana N. Micallef
Journal: Blood
Blood (2024) 144 (Supplement 1): 570.
https://doi.org/10.1182/blood-2024-199845
Published: 2024
Journal Articles

Creation of a Multistate Model to Improve Prognostication across the Disease Course in Advanced Stage Classic Hodgkin Lymphoma (cHL): A Report from the Holistic Consortium

Angie Mae Rodday, Susan K. Parsons, Zhu J Cui, Qingyan Xiang, Nicholas Counsell, Sara Rossetti, Jenica N Upshaw, Annalynn M Williams, Amy A Kirkwood, Hongli Li, James R. Cerhan, Massimo Federico, Jonathan W. Friedberg, Andrea Gallamini, Eliza A. Hawkes, David Hodgson, Martin Hutchings, Peter Johnson, Brian K. Link, Eric Mou, John Radford, Kerry J. Savage, Deborah M. Stephens, Pier Luigi Zinzani, Matthew J. Maurer, Andrew M Evens
Journal: Blood
Blood (2024) 144 (Supplement 1): 567.
https://doi.org/10.1182/blood-2024-207439
Published: 2024
Journal Articles

Real World First-Line Treatment Strategies and Outcomes in TP53 Mutated and Unmutated Mantle Cell Lymphoma

Jie Wang, Jihao Zhou, Yucai Wang, Javier L. Munoz, Kevin G. Shim, Muhamad Alhaj Moustafa, Firas Baidoun, Kaitlin Annunzio, Narendranath Epperla, Michael McLane, Yasmin H. Karimi, Binh Luu, Stephen E Spurgeon, Cheryl Chang, Zihan Wan, Diamone Gathers, Emily R. King, Marcus P. Watkins, Nancy L. Bartlett, Christine E. Ryan, Genevieve M Gerhard, Philippe Armand, Ann S. LaCasce, Vedha Vaddaraju, Danielle S Wallace, Vaishalee P Kenkre, Chase Junge, Natalie Grover, Jorge A Florindez, Reem Karmali, Alexander V. Stanisic, Chen Zhang, Parameswaran Venugopal, Grace Ying, Caitlin Gribbin, Jia Ruan, Navika D Shukla, Sonali M. Smith, Viktoriya Zelikson, Michael E. Williams, Stefan K. Barta, Omar Elghawy, Jake Schade, Rohini Navalekar, Matthew Matasar, Andrew M Evens, Alexey V. Danilov, Timothy S. Fenske
Journal: Blood
Blood (2024) 144 (Supplement 1): 4406.
https://doi.org/10.1182/blood-2024-194601
Published: 2024
Journal Articles

Extended Follow up and Immune Alterations in Patients with Classic Hodgkin Lymphoma (cHL) Treated with Frontline Single Agent Pembrolizumab Followed By AVD Chemotherapy

Pamela B. Allen, Latifa Bazzi, Bin Zhang, Qing Chen, Liron Barnea Slonim, Hatice Savas, Ranjana H. Advani, Andrew M Evens, Barbara Pro, Reem Karmali, Eric Mou, Robert Eisner, Robert Bayer, Leo I. Gordon, Jane N. Winter
Journal: Blood
Blood (2024) 144 (Supplement 1): 1664.
https://doi.org/10.1182/blood-2024-208680
Published: 2024
Journal Articles

External Validation of the Advanced-Stage Hodgkin Lymphoma International Prognostic Index (A-HIPI): Strong Calibration in the Brazilian Prospective Hodgkin Lymphoma Registry

Irene Biasoli, Valeria Buccheri, Frederico Rafael Moreira, Nelson Castro, Carolina Colaço Vilarim, Fabiola Traina, Carlos Chiattone, Monica Praxedes, Cristiana Solza, Leila Perobelli, Otavio Baiocchi, Rafael Gaiolla, Carla Boquimpani, Caroline Bonamin Sola, Roberta Oliveira P Silva, Ana Carolina Ribas, Katia Pagnano, Giovanna Steffenello, Carmino De Souza, Nelson Spector, Angie Mae Rodday, Jenica Upshaw, Matthew J. Maurer, Andrew M Evens, Susan K Parsons
Journal: Blood
Blood (2023) 142 (Supplement 1): 6200.
https://doi.org/10.1182/blood-2023-173318
Published: 2023
Journal Articles

No Place like Home: Home-Based Intravenous Arsenic Trioxide for the Treatment of Acute Promyelocytic Leukemia (APL)

Brooke Kania, David Awad, Michael Kane, Andrew M Evens, Neil Palmisiano
Journal: Blood
Blood (2023) 142 (Supplement 1): 2357.
https://doi.org/10.1182/blood-2023-190597
Published: 2023
Journal Articles

Progression-Free Survival (PFS) and Toxicity with Nivolumab-AVD Compared to Brentuximab Vedotin-AVD in Pediatric Advanced Stage (AS) Classic Hodgkin Lymphoma (cHL), Results of SWOG S1826

Sharon M. Castellino, Hongli Li, Alex F. Herrera, Angela Punnett, Michael Leblanc, Susan K Parsons, David Hodgson, Frank Keller, Richard A. Drachtman, Adam Lamble, Christopher J. Forlenza, Andrew Doan, Sarah C. Rutherford, Andrew M Evens, Richard F. Little, Malcolm A. Smith, Joo Y Song, Sonali M. Smith, Jonathan W. Friedberg, Kara M. Kelly
Journal: Blood
Blood (2023) 142 (Supplement 1): 610.
https://doi.org/10.1182/blood-2023-180107
Published: 2023
Journal Articles

AHOD2131: A Randomized Phase 3 Response-Adapted Trial Comparing Standard Therapy with Immuno-Oncology Therapy for Children and Adults with Newly Diagnosed Stage I and II Classic Hodgkin Lymphoma

Tara O. Henderson, Boyu Hu, Frank Keller, Qinglin Pei, Yue Wu, Bradford Hoppe, Sarah Milgrom, Song Yao, Niloufer Khan, Lisa Giulino Roth, Raymond Mailhot, Steve Cho, Susan K Parsons, Justine M. Kahn, Adam S Duvall, Pamela S. Hinds, Ann LaCasce, Natalie S. Grover, Pamela B. Allen, Andrew M Evens, Heiko Schoder, Sharon M. Castellino, Kara M. Kelly
Journal: Blood
Blood (2023) 142 (Supplement 1): 3084.
https://doi.org/10.1182/blood-2023-189652
Published: 2023
Journal Articles

Identification of Risk Categories from the Advanced-Stage Hodgkin International Prognostic Index (A-HIPI) Model: A Detailed Analysis from the Hodgkin Lymphoma International Study for Individual Care (HoLISTIC) Consortium

Matthew J. Maurer, Susan K Parsons, Jenica Upshaw, Jonathan W. Friedberg, Andrea Gallamini, Massimo Federico, Eliza A Hawkes, David Hodgson, Peter Johnson, Brian K. Link, Kerry J. Savage, Pier Luigi Zinzani, Andrew M Evens
Journal: Blood
Blood (2023) 142 (Supplement 1): 3067.
https://doi.org/10.1182/blood-2023-175079
Published: 2023
Journal Articles

Nivolumab-AVD Is Better Tolerated and Improves Progression-Free Survival Compared to Bv-AVD in Older Patients (Aged ≥60 Years) with Advanced Stage Hodgkin Lymphoma Enrolled on SWOG S1826

Sarah C. Rutherford, Hongli Li, Alex F. Herrera, Michael Leblanc, Sairah Ahmed, Kelly L. Davison, Carla Casulo, Nancy L. Bartlett, Joseph M Tuscano, Brian Hess, Pallawi Torka, Pankaj Kumar, Ryan W Jacobs, Joo Y Song, Sharon M. Castellino, Brad S. Kahl, John P. Leonard, Sonali M. Smith, Jonathan W. Friedberg, Andrew M Evens
Journal: Blood
Blood (2023) 142 (Supplement 1): 181.
https://doi.org/10.1182/blood-2023-180114
Published: 2023
Journal Articles

Treatment Patterns and Outcomes for Patients with Classic Hodgkin Lymphoma (cHL) and Cardiomyopathy with Low Ejection Fraction (EF): Real-World Evidence (RWE) from 16 US Academic Centers

Kaitlin Annunzio, Eric McLaughlin, Timothy Voorhees, Lauren Kelly Shea, Nuttavut Sumransub, Ashley Rose, Adam J Olszewski, Neil Bailey, Krish Patel, Tamara K. Moyo, Farrukh T. Awan, Gulrayz Ahmed, Natalie S. Grover, Adam Adika, Erica L Andres, Muhammad Salman Faisal, Beth Christian, Jacob Anna, Steven M. Bair, Nicholas Kendsersky, Colin Thomas, Pallawi Torka, Jakub Svoboda, Jordan S Carter, Mehdi Hamadani, Hayder Saeed, Sanjal H. Desai, Andrew M Evens, Narendranath Epperla
Journal: Blood
Blood (2023) 142 (Supplement 1): 382.
https://doi.org/10.1182/blood-2023-182389
Published: 2023
Journal Articles

Improved Survival of R/R Double Hit/Triple Hit Lymphoma in the Era of CD19 Chimeric Antigen T Cell (CART) Therapy

Sanjal H. Desai, Nuttavut Sumransub, Rich Evans, Marcus P Watkins, Reem Karmali, Gaurav Goyal, Mitchell E. Hughes, Arushi Khurana, Francisco J. Hernandez-Ilizaliturri, Joanna Zurko, Ayesha Hassan, Haris Hatic, Imran A. Nizamuddin, Andrew M Evens, Andrea Carolina Anampa-Guzmán, Yi Lin, Iris Isufi, Mehdi Hamadani, Saurabh A Rajguru, Naveena Lall, Aung M. Tun, Brian T. Hill, Deborah M. Stephens, Paolo F. Caimi, Daniel A. Ermann, Brad S. Kahl, Daniel J. Landsburg, Grzegorz S. Nowakowski
Journal: Blood
Blood (2023) 142 (Supplement 1): 308.
https://doi.org/10.1182/blood-2023-183001
Published: 2023
Journal Articles

Realmind: A Prospective and Retrospective Study to Characterize Real-World Use of Tafasitamab Plus Lenalidomide in US Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma, with a Focus on Patients from Minority Groups

Elizabeth A. Brem, John M. Burke, Mirko Vukcevic, Pia Kloepfer, Kimberly Saverno, Haifaa Abdulhaq, Andrew M Evens, Pierluigi Porcu, Mazyar Shadman, Christopher R. Flowers
Journal: Blood
Blood (2023) 142 (Supplement 1): 6251.
https://doi.org/10.1182/blood-2023-188482
Published: 2023
Journal Articles

Age-Based Validation of the Advanced-Stage Hodgkin Lymphoma International Prognostic Index (A-HIPI) in a Real-World Danish Study: Suboptimal Performance in Older Patients

Rasmus Rask Kragh Jørgensen, Sandra Eloranta, Jacob Haaber Christensen, Martin Hutchings, Rasmus Bo Dahl-Soerensen, Peter Kamper, Andrew M Evens, Matthew J. Maurer, Susan K Parsons, Angie Mae Rodday, Jenica Upshaw, Tarec Christoffer Christoffer El-Galaly, Lasse Hjort Jakobsen
Journal: Blood
Blood (2023) 142 (Supplement 1): 4455.
https://doi.org/10.1182/blood-2023-178498
Published: 2023
Journal Articles

Development and Validation of the Early-Stage Hodgkin Lymphoma (HL) International Prognostication Index (E-HIPI): A Report from the Hodgkin Lymphoma International Study for Individual Care (HoLISTIC) Consortium

Andrew M Evens, Angie Mae Rodday, Matthew J. Maurer, Ranjana H. Advani, Marc Andre, Andrea Gallamini, Annette E. Hay, David Hodgson, Richard T. Hoppe, Martin Hutchings, Peter Johnson, Brian K. Link, Stephen Opat, John M. Raemaekers, Jenica Upshaw, Qingyan Xiang, Nicholas Counsell, Susan K Parsons, John Radford
Journal: Blood
Blood (2023) 142 (Supplement 1): 3058.
https://doi.org/10.1182/blood-2023-173320
Published: 2023
Journal Articles

Favorable Overall Survival Following First and Second Relapse of MCL with Availability of Novel Therapies: Results from the Lion Prospective Observational Registry

David A. Bond, Jason T. Romancik, Jeffrey M. Switchenko, Brielle Berkowitz, Jonathan R Day, Umar Farooq, Sabarish Ayyappan, Katelin Baird, Michelle L. Churchman, Andrew M. Evens, Bijal D. Shah, Craig A. Portell, Kami J. Maddocks, Brian K. Link, Jonathon B. Cohen, Deborah M. Stephens
Journal: Blood
Blood (2022) 140 (Supplement 1): 6509–6511.
https://doi.org/10.1182/blood-2022-160306
Published: 2022
Journal Articles

Impact of Race and Social Determinants of Health on Outcomes in Patients with Aggressive B-Cell Lymphomas Treated with Chimeric Antigen Receptor T-Cell (CART) Therapy

Reem Karmali, Narendranath Epperla, Geoffrey Shouse, Jason T. Romancik, Tamara K. Moyo, Vaishalee P. Kenkre, Thomas A. Ollila, Lindsey A. Fitzgerald, Brian T. Hess, Andrew M. Evens, Ishan Roy, Joanna Zurko, Sayan Mullick Chowdhury, Kaitlin Annunzio, Robert Ferdman, Rahul Bhansali, Elyse I. Harris, McKenzie Sorrell, Jieqi Liu, Imran A. Nizamuddin, Shuo Ma, Jonathan Moreira, Jane N. Winter, Barbara Pro, Deborah M. Stephens, Alexey V Danilov, Nirav N. Shah, Jonathon B. Cohen, Stefan K. Barta, Pallawi Torka, Leo I. Gordon
Journal: Blood
Blood (2022) 140 (Supplement 1): 10955–10957.
https://doi.org/10.1182/blood-2022-160431
Published: 2022
Journal Articles

Development and Validation of the a dvanced-Stage H odgkin Lymphoma (HL) I nternational P rognostication I ndex (A-HIPI): A Report from the Hodgkin Lymphoma International Study for Individual Care (HoLISTIC) Consortium

Angie Mae Rodday, Susan K. Parsons, Jonathan W. Friedberg, Andrea Gallamini, Eliza Hawkes, David C. Hodgson, Peter Johnson, Brian K. Link, Eric Mou, Kerry J. Savage, Jenica Upshaw, Pier Luigi Zinzani, Matthew J. Maurer, Andrew M. Evens
Journal: Blood
Blood (2022) 140 (Supplement 1): 760–762.
https://doi.org/10.1182/blood-2022-164720
Published: 2022